- Home
- FENG vs GRCE Comparison
FENG vs GRCE Comparison
Compare FENG & GRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENG
- GRCE
- Stock Information
- Founded
- FENG 1998
- GRCE 2002
- Country
- FENG China
- GRCE United States
- Employees
- FENG N/A
- GRCE N/A
- Industry
- FENG Broadcasting
- GRCE
- Sector
- FENG Industrials
- GRCE
- Exchange
- FENG Nasdaq
- GRCE NYSE
- Market Cap
- FENG 29.7M
- GRCE 32.1M
- IPO Year
- FENG 2011
- GRCE N/A
- Fundamental
- Price
- FENG $2.11
- GRCE $2.20
- Analyst Decision
- FENG
- GRCE Strong Buy
- Analyst Count
- FENG 0
- GRCE 1
- Target Price
- FENG N/A
- GRCE $12.00
- AVG Volume (30 Days)
- FENG 6.0K
- GRCE 27.2K
- Earning Date
- FENG 05-12-2025
- GRCE 05-15-2025
- Dividend Yield
- FENG N/A
- GRCE N/A
- EPS Growth
- FENG N/A
- GRCE N/A
- EPS
- FENG N/A
- GRCE N/A
- Revenue
- FENG $96,408,461.00
- GRCE N/A
- Revenue This Year
- FENG N/A
- GRCE N/A
- Revenue Next Year
- FENG N/A
- GRCE N/A
- P/E Ratio
- FENG N/A
- GRCE N/A
- Revenue Growth
- FENG 1.69
- GRCE N/A
- 52 Week Low
- FENG $1.67
- GRCE $2.07
- 52 Week High
- FENG $4.15
- GRCE $4.97
- Technical
- Relative Strength Index (RSI)
- FENG 42.12
- GRCE N/A
- Support Level
- FENG $2.10
- GRCE N/A
- Resistance Level
- FENG $2.33
- GRCE N/A
- Average True Range (ATR)
- FENG 0.10
- GRCE 0.00
- MACD
- FENG -0.01
- GRCE 0.00
- Stochastic Oscillator
- FENG 20.00
- GRCE 0.00
About FENG Phoenix New Media Limited
Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives revenue from China.
About GRCE GRACE THERAPEUTICS INC
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.